首页> 外文期刊>International journal of molecular medicine >Prediction of the molecular mechanisms and potential therapeutic targets for diabetic nephropathy by bioinformatics methods
【24h】

Prediction of the molecular mechanisms and potential therapeutic targets for diabetic nephropathy by bioinformatics methods

机译:通过生物信息学方法预测糖尿病肾病的分子机制和潜在的治疗靶点

获取原文
       

摘要

In this study, we aimed to explore the molecular mechanisms of and genetic factors influencing diabetic nephropathy?(DN). Gene expression profiles associated with DN were obtained from the GEO database (Accession?no.?GSE20844). The differentially expressed genes?(DEGs) between diabetic mice and non-diabetic mice were screened. Subsequently, the DEGs were subjected to functional and pathway analysis. The protein-protein interaction?(PPI) network was constructed and the transcription factors?(TFs) were screened among the DEGs. A total of 92?upregulated and 118?downregulated genes were screened. Pathway analysis revealed that the p53?signaling pathway, the transforming growth factor (TGF)-β signaling pathway and the mitogen-activated protein kinase?(MAPK) signaling pathway were significantly enriched by upregulated genes. Serpine1?(also known as plasminogen activator inhibitor-1), early growth response?1?(Egr1) and Mdk were found to be significant nodes in the PPI?network by three methods. A total of 12?TFs were found to be differentially expressed, of which nuclear receptor subfamily?4, group?A, member?1?(Nr4a1) and peroxisome proliferator-activated receptor gamma?(Pparg) were found to have multiple interactions with other DEGs. We demonstrated that the p53?signaling pathway, the TGF-β signaling pathway and the MAPK signaling pathway were dysregulated in the diabetic mice. The significant nodes (Serpine1, Egr1 and Mdk) and differentially expressed TFs (Nr4a1 and Pparg) may provide a novel avenue for the targeted therapy of DN.
机译:在这项研究中,我们旨在探讨影响糖尿病肾病(DN)的分子机制和遗传因素。与DN相关的基因表达谱从GEO数据库(登录号:GSE20844)获得。筛选了糖尿病小鼠和非糖尿病小鼠之间的差异表达基因(DEG)。随后,对DEG进行功能和途径分析。构建了蛋白质间相互作用网络(PPI),并在DEGs之间筛选了转录因子(TFs)。共筛选了92个上调和118个下调的基因。通路分析表明,上调基因显着丰富了p53信号通路,转化生长因子(TGF)-β信号通路和丝裂原活化蛋白激酶(MAPK)信号通路。通过三种方法,发现Serpine1?(也称为纤溶酶原激活物抑制剂-1),早期生长反应?1?(Egr1)和Mdk是PPI?网络中的重要节点。发现总共有12个TFs差异表达,其中核受体亚家族?4,组?A,成员?1?(Nr4a1)和过氧化物酶体增殖物激活的受体γ?(Pparg)具有多种相互作用。其他DEG。我们证明了糖尿病小鼠中p53信号通路,TGF-β信号通路和MAPK信号通路失调。重要结节(Serpine1,Egr1和Mdk)和差异表达的TF(Nr4a1和Pparg)可能为DN的靶向治疗提供新途径。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号